Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 3, 1997, Pages 247-252

  Von Nicolai, Hubertus ^a,c   Brickl, Rolf ^a   Eschey, Hans ^a   Greischel, Andreas ^a   Heinzel, Günther ^a   König, Erwin ^a   Limmer, Jörg ^b   Rupprecht, Eckhard ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

^c Dept Pharmacokin and Drug Metab ^*  (Germany)

Author keywords

antidiabetics, oral; AR DF 26 SE, duration of action, pharmacokinetics; Beglynor ; CAS 33342 05 1; gliquidone; Glurenorm ; sulfonylureas

Indexed keywords

AR DF 26 SE; BEGLYNOR; GLIQUIDONE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; SINGLE BLIND PROCEDURE;

AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HALF-LIFE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY CONTROL; SINGLE-BLIND METHOD; SPECTROMETRY, FLUORESCENCE; SULFONYLUREA COMPOUNDS;

EID: 0030959861     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lebovitz, H. E., Sulfonylurea Drugs, in: Therapy for diabetes mellitus and related disorders, H. E. Lebovitz (ed.), American Diabetes Association (1991)
2. Groop, L. C., Diabetes Care 15, 737 (1992)
3. Pothoff, G., Siebert, K., Bach, I. et al., Akt. Endokrinol. Stoffwechsel 10, 218 (1989)
4. Müller-Esch, G., Internist 31, 191 (1990)
5. Beyer, J., Verh. Dtsch. Ges. Inn. Med. 93, 275 (1987)
6. Alberti, K. G. M. M., Gries, F. A., Diabetic Med. 5, 275 (1988)
7. Physicians Guide to Non-Insulin-Dpendent (Type II) Diabetes: Diagnosis and Treatment, American Diabetes Association; Clinical Education Program H. Rifkin (ed., 2nd ed., Alexandria, Virginia (1988)
8. Karam, J. H., Endocrinol. Metab. Clin. North Am. 21, 329 (1992)
9. Lefebvre, P. J., Scheen, A. J., Drugs 44 (Suppl. 3), 29 (1992)
10. Melander, A., Lebovitz, H. E., Faber, O. K., Diabetes Care 13 (Suppl. 3), 18 (1990)
11. Karam, H. J., Sanz, N., Salomon, E. et al., Diabetes 35, 1314 (1986)
12. Faber, O. K., Beck-Nielsen, H., Binder, C. et al., Diabetes Care 13 (Suppl. 3), 26 (1990)
13. Bitzen, P. O., Melander, A., Schersten, B. et al., Eur. J. Clin. Pharmacol. 42, 77 (1992)
14. Hellman, B., Sehlin, J., Täljedal, I. B., Acta Endocrinol. 105, 385 (1984)
15. Carpentier, J. L., Sawano, F., Ravazzola, M. et al., Diabetologia 29, 259 (1986)
16. Gorus, F. K., Schuit, F. C., In't Veld, P. A. et al., Diabetes 37, 1090 (1988)
17. Verspohl, E. J., Ammon, H. P. T., Mark, M., J. Pharm. Pharmacol. 42, 230 (1989)
18. Kopitar, Z., Koss, F. W., Arzneim.-Forsch./Drug Res. 25 (II), 1933 (1975)
19. Limmer, J., König, E., Rupprecht, E. et al., Diabetol. Croat. 20 (Suppl. I), 3 (1992)
20. Kopitar, Z., Arzneim.-Forsch./Drug Res. 25 (II), 1455 (1975)
21. Kopitar, Z., Kompa, H. E., Arzneim.-Forsch./Drug Res. 25 (II), 1469 (1975)
22. Koss, F. W., Kopitar, Z., Hammer, R., Diabetol. Croat. 5, 355 (1976)
23. Koss, F. W., Therapiewoche 26, 8541 (1976)
24. Roth, W., Beschke, K., J. Pharm. Biomed. Anal. 2, 289 (1984)
25. Heinzel, G., Woloszczak, R., Thomann, P., TopFit 2.0, Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC, Gustav Fischer, Stuttgart-Jena-New York (1993)
26. Heng, W., Dating, L., Diabetol. Croat. 18 (3/Suppl.), 15 (1989)